These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16868219)

  • 21. Lack of interaction between sertraline and lamotrigine in psychiatric patients: a retrospective study.
    Christensen J; Sandgaard AP; Sidenius P; Linnet K; Licht RW
    Pharmacopsychiatry; 2012 May; 45(3):119-21. PubMed ID: 22426846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic drug monitoring of lamotrigine.
    Chong E; Dupuis LL
    Ann Pharmacother; 2002 May; 36(5):917-20. PubMed ID: 11978172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placebo.
    Goldberg JF; Calabrese JR; Saville BR; Frye MA; Ketter TA; Suppes T; Post RM; Goodwin FK
    J Clin Psychiatry; 2009 Sep; 70(9):1273-80. PubMed ID: 19689918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lamotrigine. A new possibility in the treament of epilepsy].
    Mai J
    Ugeskr Laeger; 1996 Apr; 158(14):1994-7. PubMed ID: 8650779
    [No Abstract]   [Full Text] [Related]  

  • 25. Successful treatment with lamotrigine in bipolar depression: a study from Turkey.
    Savas HA; Selek S; Bulbul F; Kaya MC; Savas E
    Aust N Z J Psychiatry; 2006 May; 40(5):498-500. PubMed ID: 16683978
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical pharmacokinetic interactions between lamotrigine and hormonal contraceptives in bipolar I disorder.
    Sawagashira R; Fujii Y; Kusumi I
    Psychiatry Clin Neurosci; 2017 Apr; 71(4):290. PubMed ID: 28191687
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design.
    van der Loos ML; Mulder P; Hartong EG; Blom MB; Vergouwen AC; van Noorden MS; Timmermans MA; Vieta E; Nolen WA;
    Bipolar Disord; 2011 Feb; 13(1):111-7. PubMed ID: 21320258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjunctive lamotrigine therapy for patients with bipolar II depression partially responsive to mood stabilizers.
    Chang JS; Moon E; Cha B; Ha K
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1322-6. PubMed ID: 20673782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of lamotrigine in bipolar disorder in a clinical setting.
    Ketter TA; Brooks JO; Hoblyn JC; Champion LM; Nam JY; Culver JL; Marsh WK; Bonner JC
    J Psychiatr Res; 2008 Nov; 43(1):13-23. PubMed ID: 18423667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child.
    Rambeck B; Kurlemann G; Stodieck SR; May TW; Jürgens U
    Eur J Clin Pharmacol; 1997; 51(6):481-4. PubMed ID: 9112063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lamotrigine and its applications in the treatment of epilepsy and other neurological and psychiatric disorders.
    Malik S; Arif H; Hirsch LJ
    Expert Rev Neurother; 2006 Nov; 6(11):1609-27. PubMed ID: 17144777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lamotrigine add-on to valproate therapy for paediatric bipolar affective disorder.
    Thakur A; Jagadheesan K; Sinha VK
    Aust N Z J Psychiatry; 2005 Jul; 39(7):639. PubMed ID: 15996148
    [No Abstract]   [Full Text] [Related]  

  • 33. Lamotrigine in mood disorders.
    Green B
    Curr Med Res Opin; 2003; 19(4):272-7. PubMed ID: 12841919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lamotrigine serum concentrations under valproate comedication: "contraindication" or "safe combination"? A case report.
    Greiner C; Wittmann M; Haen E
    Pharmacopsychiatry; 2007 Nov; 40(6):287-9. PubMed ID: 18030653
    [No Abstract]   [Full Text] [Related]  

  • 35. Reduced absorption of lipophilic anti-epileptic medications when used concomitantly with the anti-obesity drug orlistat.
    Bigham S; McGuigan C; MacDonald BK
    Epilepsia; 2006 Dec; 47(12):2207. PubMed ID: 17201727
    [No Abstract]   [Full Text] [Related]  

  • 36. Lamotrigine in pregnancy and lactation: a case report.
    Tomson T; Ohman I; Vitols S
    Epilepsia; 1997 Sep; 38(9):1039-41. PubMed ID: 9579945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addition of lamotrigine to valproic acid: a successful outcome in a case of rapid-cycling bipolar affective disorder.
    da Rocha FF; Soares FM; Correa H; Teixeira AL
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1548-9. PubMed ID: 17630063
    [No Abstract]   [Full Text] [Related]  

  • 39. Lamotrigine added to valproate successfully treated a case of ultra-rapid cycling bipolar disorder.
    Woo YS; Chae JH; Jun TY; Bahk WM
    Psychiatry Clin Neurosci; 2007 Feb; 61(1):130-1. PubMed ID: 17239053
    [No Abstract]   [Full Text] [Related]  

  • 40. The impact of pregnancy and childbirth on the metabolism of lamotrigine.
    Pennell PB; Newport DJ; Stowe ZN; Helmers SL; Montgomery JQ; Henry TR
    Neurology; 2004 Jan; 62(2):292-5. PubMed ID: 14745072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.